AERIFY-1 study met its primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers regardless of eosinophilic phenotype and provided a clinically ...
Sanofi and Regeneron’s Dupixent (dupilumab) has received positive final draft guidance from the National Institute for Health ...
Both indoor and outdoor air quality impact chronic obstructive pulmonary disease (COPD), which opens up a large avenue to work with patients to improve their outcomes. For COPD patients, the adage ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Between smokers with COPD and healthy nonsmokers, ...
The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a ...
Smokers who have chronic obstructive pulmonary disorder (COPD) may face nearly twice the risk of getting small cell lung cancer (SCLC)--the deadliest form of lung cancer--than smokers who don't have ...
Miami (March 13, 2025) – For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased chest muscle loss, according to a new study. The ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Factors included smoking status, cigarette ...
For each year of increase in menopausal age, COPD risk was reduced by 1.2%, and current smokers reached menopause 1.402 years earlier than never smokers. Menopausal age has a strong association with ...
May 9 (UPI) --Smoking can't explain why women are more at risk for COPD, a new study says. Women are about 50% more likely than men to develop COPD even though they are less likely to smoke, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results